Trial intelligence / Profile preview

Nerve Block vs Antiemetics for PONV in Inner Ear Surgery

NCT02724033Phase 4Terminated

Sponsor
Indiana University
Start
May 2014
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Indiana University. Primary endpoint: Evidence of Post Operative Nausea and Vomiting at 24 hours. Started May 2014; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT02724033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02724033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call